HomeProductsBuilding BlocksOrganic Building BlocksBenzene Compounds3-t-Butyl-4-hydroxyanisole
Chemical structure of CAS 121-00-6

3-t-Butyl-4-hydroxyanisole

In Stock•Starting at $8 for 5 g•Purity ≥ 97%
CAS No.121-00-6
MDL No.MFCD00040484
MFC11H16O2
MW180.24
InChI KeyMRBKEAMVRSLQPH-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 g97%$8In Stock
10 g97%$9In Stock
25 g97%$12In Stock
100 g97%$33In Stock
500 g97%$134In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

3-tert-Butyl-4-hydroxyanisole is an aromatic ether and a phenol, structurally derived from 4-methoxyphenol by replacing one hydrogen ortho to the phenolic hydroxy group with a tert-butyl group. It functions as an antioxidant and is a human xenobiotic metabolite.

CAS No.121-00-6
Product Name3-t-Butyl-4-hydroxyanisole
IrritantIrritant
Health HazardHealth Hazard
Environmental HazardEnvironmental Hazard
Signal Word:Warning
HCode:H315-H319-H351-H361-H411
PCode:P203-P264-P264+P265-P273-P280-P302+P352-P305+P351+P338-P318-P321-P332+P317-P337+P317-P362+P364-P391-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.

Journal of molecular graphics & modelling • Vol. 25, Issue 3 • 2006
PMID: 16497524DOI: 10.1016/j.jmgm.2006.01.007

Characterization of hydroxyaromatic compounds in vegetable oils by capillary electrophoresis with direct injection in an oil-miscible KOH/propanol/methanol medium.

Electrophoresis • Vol. 26, Issue 17 • 2005
PMID: 16097022DOI: 10.1002/elps.200410394

Solid-state nuclear magnetic resonance determination of the physical form of BHA on common pharmaceutical excipients.

Pharmaceutical research • Vol. 21, Issue 1 • 2004
PMID: 14984274DOI: 10.1023/b:pham.0000012168.44628.ed

Molecular mechanism of cell death induced by the antioxidant tert-butylhydroxyanisole in human monocytic leukemia U937 cells.

Biological & pharmaceutical bulletin • Vol. 27, Issue 3 • 2004
PMID: 14993791DOI: 10.1248/bpb.27.295

Documentation

Similar Products